Byron Vaughn, MD
Gastroenterology · Minneapolis, MNNPI 1255503223
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $35,375 of the $45,533 with a category attached, or 77.7%. Every reported general payment came from a single manufacturer, AbbVie. Reporting peaked in 2019 at $28,992 and has fallen 99.9% since, to $29 in 2023. Among gastroenterology clinicians in MN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 62 payments — averaging $734.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$46K
Across 147 payments — averaging $3126.30 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$177K
- Takeda Pharmaceuticals U.S.A., Inc.$151K
- Pfizer$75K
- Diasorin Inc.$28K
- Nestle Healthcare Nutrition Inc.$16K
- Gilead$13K
What the payments were for
- Consulting fees$6501%
- Speaking & faculty fees$35,37578%
- Travel & lodging$8,54819%
- Food & beverage$9392%
- Education$220%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 62 | $45,533 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$45,533 in reported general payments places this provider in the 90th percentile of 365 gastroenterology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Vancomycin Hcl | 12 | $3,059 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Minneapolis
- Joshua SloanMinneapolis$175K
- Stuart AmateauMinneapolis$123K
- Justin HowardMinneapolis$50K
- Guru TrikudanathanMinneapolis$46K
- Martin FreemanMinneapolis$32K
- Sasan MosadeghiMinneapolis$14K
- Nabeel AzeemMinneapolis$12K
- David LeungMinneapolis$12K
- John LakeMinneapolis$11K
- John KisielRochester$856K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.